本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

4.99
-0.0500-0.99%
盤後4.80-0.1900-3.81%19:30 EDT
成交量:3.45萬
成交額:17.21萬
市值:3,116.06萬
市盈率:-0.68
高:5.45
開:5.04
低:4.82
收:5.04
52周最高:13.69
52周最低:3.98
股本:624.46萬
流通股本:370.27萬
量比:0.83
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
淨資產收益率:-113.59%
總資產收益率:-49.12%
市淨率:0.98
市盈率(LYR):-2.04

資料載入中...

2025/06/26

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/06

重要事件披露

Form 8-K - Current report
2025/04/02

SEC問詢函

Form CORRESP - Correspondence
2025/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/11/15

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/09/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors